Pharmaceutical Company Drives New Levels of Data Acceptability

What do you do when there are large discrepancies in your data? Download this case study to learn how a leading global pharmaceutical company overcame this challenge.

You’ll gain insight into how a new study design that leveraged ERT Respiratory solutions and Portfolio Business Intelligence was the key to success – improving statistical outcomes and reducing site data quality issues. You’ll learn how ERT:

  • Generated higher-quality data for regulatory submission
  • Drove data acceptability to 95%+
  • Achieved database lock on schedule, and more!

By submitting this form you are consenting to receiving digital communications from ERT. You may opt-out at any time.